Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $3.21 | Change: $-0.08 | %Change: -2.43%
Volume: 2,851 | Day High/Low: 3.25/3.21 | 52 Week High/Low: 5.73/1.35


View modes: 
5 stars

RE:RE:RE:Very interesting day of trading

I agree whole heartedly with both consultant and paljoey. Couldn't state it anymore clearer myself!  rate and reply
5 stars

RE:RE:Very interesting day of trading

Those warrants will add about $2.5 million to coffers and cant be trading until August. By then, GUD will have swallowed us.  rate and reply
5 stars

RE:Very interesting day of trading

I am an old-timer. I can't remember the last time this stock went up unless it was in anticipation of some expected outcome or event like an FDA decision of a new drug application. I certaintly can't...read more
3 stars

RE:RE:Very interesting day of trading

Your the  moron, because I never held my stock once they announced the stock consolidation, I bought back in after the storm settled on the share price. So when it goes up 10-30 cents, I actually make...read more
3.5 stars

RE:RE:Very interesting day of trading

A long journey starts with a single step.  rate and reply
3.5 stars

RE:Very interesting day of trading

ronz wrote: The old time owners of NRI will know what I mean when I say that "Today was a very interesting day of trading in NRI." Just like back in the old days, as its been a while since I saw a day...read more
2 stars

Very interesting day of trading

The old time owners of NRI will know what I mean when I say that "Today was a very interesting day of trading in NRI." Just like back in the old days, as its been a while since I saw a day like this...read more
2 stars

RE:RE:fqubed

Its nice to see the Little a Folk getting  scruwed again. They seem to like going down better tho...  rate and reply
0 stars

This was picked up by Roger Dent at Quinsam Capital at $2.25

Quinsam participated in the recent new issue at $2.25/unit by Nuvo Research Inc. (“NRI”). NRI  is a life science company that has both products on the market generating significant revenue  and...read more
5 stars

RE:fqubed

Yes I totally agree! Time to focus on the real value in the company while non-management shareholders still have a piece worth something.  rate and reply
5 stars

fqubed

It's about time these morons monetize our investment in penetration enhancers. Move into formulations other then pain!  rate and reply
2.5 stars

RE:RE:Novo ranked in top 10 performers in 2014

Has rock07 denied or confirmed yet this suggested connection to Nuvo? Just interested to know.  rate and reply
4 stars

Now We Know Something is up ...

Suspicious - the company issues new shares and instead of going down to reflect the dilution the stock price goes up. There is a clause that allows the company to call the warrants if the 10-day...read more
2.5 stars

More Good News..Two more drugs

uvo, Ferndale, CRO to develop dermatology products 2014-04-23 07:44 ET - News Release   Mr. Dan Chicoine reports NUVO RESEARCH ANNOUNCES COLLABORATION TO DEVELOP TOPICAL DERMATOLOGY PRODUCTS ...read more
3.5 stars

RE:Mallinckrodt, Nuvo Sue Metrics Over Generic Pennsaid Share

They can't make money selling the stuff, perhaps suing is the the way top go. It is playing into management's core competency - litigation.  rate and reply
4 stars

RE:RE:What is this really worth

ha ha ha ha ha.....that's a good one..... rock, aka superwatch, aka Dan/John, spare us the nonsense. Speaking for myself, and a few dozen other shareholders, nothing would be better than a high...read more
5 stars

Mallinckrodt, Nuvo Sue Metrics Over Generic Pennsaid Share

http://www.law360.com/articles/530343/mallinckrodt-nuvo-sue-metrics-over-generic-pennsaid Mallinckrodt, Nuvo Sue Metrics Over Generic Pennsaid Share us on: Twitter Facebook LinkedIn By...read more
1 star

RE:What is this really worth

where do you get this will get a Nasdaq listing?  rate and reply
2.5 stars

Consultant

You are clearly very upset about the way insiders have enriched themselves. My question to you is, other than being upset, what do you plan to do to remedy your cognitive dissonance?  rate and reply
2 stars

RE:What is this really worth

$12 to $15 by Sept? That would mean that shareholders will get rich along with management. The little folk holding their 38 shares won't like that one bit. If they had their way, the share price...read more